The primary defining feature of CML for diagnosis is the presence of the BCR::ABL1 chimeric fusion oncogene, or Philadelphia chromosome (Ph), which arises from a t(9;22)(q34;q11) translocation between chromosomes 9 and 22 [2]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.